Federal Judge Pens Start Date for Bellwether Case Selection, Relays Details for Discovery in GranuFlo Lawsuit Litigation
A federal judge overseeing GranuFlo lawsuit claims currently pending in the District of Massachusetts has begun to set guidelines for the exchange of documents and other information vital to the discovery phase of the litigation, according to a recent court order.
Issued on October 1st, a new Case Management Order has established certain protocol for the next stage of the federal proceeding, which involves lawsuits alleging catastrophic heart injuries caused by two dialysates, GranuFlo and NaturaLyte. According to the order, the process of selecting the litigation’s first bellwether cases, which will hopefully serve as a benchmark of how juries will rule in similar actions over either of the dialysis medications, is scheduled to begin on January 6, 2014.
At Least 229 GranuFlo Lawsuit Filings Now Pending in Federal Massachusetts Litigation
A recent update from the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicates that at least 229 Fresenius lawsuits had been filed in the federal proceeding as of September 2013. In July, Fresenius Medical Care had acknowledged its involvement in just 33 GranuFlo and NaturaLyte-related cases.
The medications at the center of this litigation were administered during dialysis treatments prior to their recall in June 2012 and manufactured by Fresenius Medical Care.
Cases now pending in the federal GranuFlo and NaturaLyte proceeding similarly allege that recipients may experience sudden cardiac arrest, cardiopulmonary arrest, heart attacks and other injuries after use of the dialysis medications. Plaintiffs further allege that Fresenius was too late in issuing its Urgent Product Notification in March 2012 that warned of their heart-related side effects. According to lawsuits, the company also sent an internal memo to physicians operating in its dialysis clinics in November 2011 that alerted them of 900 patient deaths that had occurred after GranuFlo usage, and advised that dosages of the medication be adjusted to prevent further fatalities. Doctors operating outside the Fresenius network were not alerted of any danger associated with the drugs prior to the GranuFlo recall.
In addition to the federal litigation, Fresenius claims filed at the state court level have been consolidated in Middlesex County Superior Court in Massachusetts. This proceeding will affect all lawsuits filed in Massachusetts state court.
File a GranuFlo Recall Lawsuit Today
If your loved one sustained fatal or near-fatal GranuFlo or NaturaLyte heart injuries within 72 hours of receiving either of the dialysis medications, the time is now to file a lawsuit seeking compensation for damages. Call us today at (877) 779-1414 to learn more.